Los puntos clave no están disponibles para este artículo en este momento.
The past 30 years have seen major shifts in cardiovascular science and medicine. In the United States, mortality due to cardiovascular disease (CVD) has declined by more than 60% as a result of new therapeutic approaches, including the introduction of statins, better anticoagulants, angiotensin-converting enzyme inhibitors, devices such as implantable cardioverter-defibrillators, and�perhaps foremost�the application of evidence-based scientific guidelines.
Zoghbi et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: